GlassScriptPhysician profile
Shawn M Weigel
NPI 1467455675
$1,961.05
in general payments reported to CMS, 2019-2025
19 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $142 · 2021: $363 · 2022: $275 · 2023: $193 · 2024: $280 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $496.64 | 2019-2025 | Hydrus Microstent, Eysuvis, Rocklatan |
| Abbvie INC. | $301.49 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Sun Pharmaceutical Industries INC. | $208.87 | 2019-2025 | Cequa |
| Sight Sciences, INC. | $180.56 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Dompe US, INC. | $149.72 | 2021-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $105.42 | 2019-2025 | Tecnis Simplicity, Amo Phaco Needle |
| Glaukos Corporation | $86.40 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $67.31 | 2022-2024 | Vyzulta, Miebo |
| Oyster Point Pharma, INC. | $58.31 | 2023-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.59 | 2019-2020 | |
| Harrow Eye, LLC | $52.08 | 2025 | |
| Mallinckrodt Hospital Products INC. | $42.29 | 2021 | |
| Allergan, INC. | $38.61 | 2020 | |
| Aerie Pharmaceuticals, INC. | $31.37 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $29.45 | 2025 | Xdemvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $19.52 | 2025 | Dextenza |
| Novartis Pharmaceuticals Corporation | $15.18 | 2023 | |
| New World Medical,INC. | $11.27 | 2025 | Via360, Ahmed Glaucoma Valve, Clearpath |
| Eyevance Pharmaceuticals LLC | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Weigel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.